相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide
Amy E. DeZern et al.
BLOOD ADVANCES (2021)
Decline in IGF1 in the bone marrow microenvironment initiates hematopoietic stem cell aging
Kira Young et al.
CELL STEM CELL (2021)
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse
Laura F. Newell et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation
Wing Hing Wong et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation
Steffen Boettcher et al.
BLOOD (2020)
Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management
Matthew D. Seftel et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102
Ryotaro Nakamura et al.
BLOOD (2020)
Single-cell mutation analysis of clonal evolution in myeloid malignancies
Linde A. Miles et al.
NATURE (2020)
Clonal hematopoiesis and risk of acute myeloid leukemia
Andrew L. Young et al.
HAEMATOLOGICA (2019)
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
Lucas P. Wachsmuth et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors
Michael A. Pulsipher et al.
HAEMATOLOGICA (2019)
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation
Mareike Frick et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A
Manuel Buscarlet et al.
BLOOD (2018)
Prediction of acute myeloid leukaemia risk in healthy individuals
Sagi Abelson et al.
NATURE (2018)
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
M. J. Christopher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide
Shannon R. McCurdy et al.
BLOOD ADVANCES (2018)
Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation
S. Kobayashi et al.
LEUKEMIA (2017)
Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient
S. Herold et al.
LEUKEMIA (2017)
Effector CD8 T cells dedifferentiate into long-lived memory cells
Ben Youngblood et al.
NATURE (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias
Christopher J. Gibson et al.
BLOOD (2017)
De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation
Hazem E. Ghoneim et al.
CELL (2017)
Clinical significance of somatic mutation in unexplained blood cytopenia
Luca Malcovati et al.
BLOOD (2017)
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
Craig Kollman et al.
BLOOD (2016)
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy
Katarzyna Rojek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation
L. P. Gondek et al.
LEUKEMIA (2016)
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults
Andrew L. Young et al.
NATURE COMMUNICATIONS (2016)
Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms
Chantana Polprasert et al.
CANCER CELL (2015)
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Yvette L. Kasamon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers
David A. Russler-Germain et al.
CANCER CELL (2014)
Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
Christopher G. Kanakry et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Large conserved domains of low DNA methylation maintained by Dnmt3a
Mira Jeong et al.
NATURE GENETICS (2014)
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry
Loren Gragert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enrichment of IL-12-Producing Plasmacytoid Dendritic Cells in Donor Bone Marrow Grafts Enhances Graft-versus-Leukemia Activity in Allogeneic Hematopoietic Stem Cell Transplantation
Katarzyna A. Darlak et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells
Soo Jin Kim et al.
BLOOD (2013)
A disease risk index for patients undergoing allogeneic stem cell transplantation
Philippe Armand et al.
BLOOD (2012)
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
M. J. Walter et al.
LEUKEMIA (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection
Megan T. Baldridge et al.
NATURE (2010)
DNMT3A Mutations in Acute Myeloid Leukemia.
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
V Reddy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
分享论文
